Harbin Medical University | China
Profile Verified:
✅ Suitability Summary:
Dr. Chuanmeng Zhang With a solid academic background and over seven years of hands-on experience in medical research, Dr. Zhang is exceptionally well-suited for roles in public health analytics, clinical research coordination, and data-driven epidemiological studies. His expertise in managing hospital research datasets and translating them into internationally recognized publications reflects his analytical capabilities and leadership in collaborative research environments.
📚 Education & Experience:
Dr. Chuanmeng Zhang, born in October 1991 in Shandong, China, is currently pursuing his Ph.D. in Epidemiology and Health Statistics at Harbin Medical University (since September 2024). Prior to this, from August 2017 to August 2024, he worked at the Central Laboratory of Taizhou People’s Hospital, where he was primarily responsible for the statistical analysis of scientific research. His contributions during this period led to the publication of more than 10 SCI-indexed papers as the first or corresponding author. He earned his Master’s degree in Clinical Epidemiology from Guangdong Medical University in July 2017, laying a strong academic foundation for his ongoing work in clinical and public health research.
📜 Professional Development:
Dr. Zhang has consistently expanded his professional skill set through practical and academic engagements. He is proficient in various statistical and epidemiological tools and has developed a strong grasp of research methodology, clinical data interpretation, and scholarly writing. His current Ph.D. work further enhances his theoretical and practical knowledge in epidemiology, making him a valuable asset in any research-intensive environment.
🔬 Research Focus:
Dr. Zhang’s research primarily targets cardiovascular diseases and tumor epidemiology, areas that are central to global public health. His work involves analyzing large clinical datasets, developing predictive models, and investigating risk factors and outcomes related to these diseases. He also demonstrates interest in survival analysis, clinical trial interpretation, and epidemiological modeling.
🏆 Honors & Achievements:
Dr. Zhang has authored over 10 SCI papers as a first or corresponding author, establishing himself as a key contributor in the domains of cardiovascular and cancer research. His scholarly output and analytical contributions have played a significant role in enhancing the research profile of Taizhou People’s Hospital, reflecting both academic rigor and real-world impact.
📚 Selected Publication:
Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis
Authors: Chuanmeng Zhang; Chenglin Zhou; Jie Xu; Shanshan Xue; Alexander G Mathioudakis
Journal: Disease Markers
Year: 2022